Uveitis and Systemic lupus erythematosus

Summary:

Systemic lupus erythematosus is found among people with Uveitis, especially for people who are female, 60+ old.

The study analyzes which people have Systemic lupus erythematosus with Uveitis. It is created by eHealthMe based on reports of 75 people who have Uveitis from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Uveitis?

Uveitis (inflammation of the uvea) is found to be associated with 830 drugs and 1,533 conditions by eHealthMe. Check the latest studies of Uveitis.

What is Systemic lupus erythematosus?

Systemic lupus erythematosus (an autoimmune disease, which means the body's immune system mistakenly, attacks healthy tissue) is found to be associated with 1,087 drugs and 1,646 conditions by eHealthMe. Check the latest studies of Systemic lupus erythematosus.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Sep, 01, 2026

75 people who have Uveitis and Systemic Lupus Erythematosus are studied.

Would you have Systemic lupus erythematosus when you have Uveitis?

Gender of people who have Uveitis and experienced Systemic Lupus Erythematosus *:

  • female: 97.01 %
  • male: 2.99 %

Age of people who have Uveitis and experienced Systemic Lupus Erythematosus *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 3.5700000000000003 %
  • 20-29: 14.29 %
  • 30-39: 7.14 %
  • 40-49: 14.29 %
  • 50-59: 21.43 %
  • 60+: 39.29 %

Common co-existing conditions for these people *:

  1. Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 5 people, 6.67%
  2. Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 5 people, 6.67%
  3. Ankylosing Spondylitis (type of arthritis affecting the spine): 3 people, 4.00%
  4. Ulcerative Colitis (inflammatory bowel disease (ibd). it causes swelling, ulcerations, and loss of function of the large intestine): 2 people, 2.67%
  5. Psoriasis (immune-mediated disease that affects the skin): 2 people, 2.67%
  6. Eye Inflammation: 2 people, 2.67%
  7. Depression: 2 people, 2.67%
  8. Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 2 people, 2.67%
  9. Scleritis (inflammation of sclera): 1 person, 1.33%
  10. Juvenile Rheumatoid Arthritis (joint inflammation in children due to systemic disease): 1 person, 1.33%

Common drugs taken by these people *:

  1. Humira: 64 people, 85.33%
  2. Remicade: 6 people, 8.00%
  3. Cellcept: 4 people, 5.33%
  4. Prednisone: 3 people, 4.00%
  5. Inflectra: 2 people, 2.67%
  6. Singulair: 2 people, 2.67%
  7. Durezol: 2 people, 2.67%
  8. Vitamin D: 1 person, 1.33%
  9. Cosentyx: 1 person, 1.33%
  10. Dilantin: 1 person, 1.33%

Common symptoms for these people *:

  1. Joint Pain: 9 people, 12.00%
  2. Inflammation: 8 people, 10.67%
  3. Pain: 7 people, 9.33%
  4. Drug Ineffective: 7 people, 9.33%
  5. Psoriasis (immune-mediated disease that affects the skin): 6 people, 8.00%
  6. Fall: 5 people, 6.67%
  7. Fatigue (feeling of tiredness): 5 people, 6.67%
  8. Back Pain: 5 people, 6.67%
  9. Rashes (redness): 5 people, 6.67%
  10. Injection Site Pain: 4 people, 5.33%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Systemic lupus erythematosus?

- Check whether Systemic lupus erythematosus is associated with a drug or a condition


Related publications that referenced our studies

Related studies:

Treatments, associated drugs and conditions:

All the drugs that are associated with Systemic lupus erythematosus:

All the conditions that are associated with Systemic lupus erythematosus:


How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Systemic lupus erythematosus and Uveitis, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: